Study of how the body controls DNA “jumping genes” before birth
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at how the body stops “jumping genes” (transposons) during fetal development, specifically in male fetuses. Families may be able to participate if the fetus is obtained from a planned pregnancy termination and meets the timing and screening requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A couple or mother must give written consent to join the study.
- The pregnancy must be 10 to 37 weeks by the study’s counting method (amenorrhea weeks).
- The fetus must be male.
- The fetus must be obtained after a planned pregnancy termination (medical or voluntary).
- The family must have national health insurance coverage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a baby’s organs develop in late pregnancy, using situations where someone is already being evaluated for a possible fetal abnormality and chooses to end the pregnancy. The goal is to better understand late-stage fetal development and related causes of abnormalities.
This study looks at gene activity in the placenta during early and full-term pregnancy. It may help researchers understand how the placenta works and how it affects both mother and baby.
This study examines genetic material from miscarriages to understand why early pregnancy loss happens. Researchers analyze a blood sample taken right after miscarriage to look for clues that might help explain what went wrong and potentially prevent future losses.
This study looks at the genetics of fetuses with sex chromosome disorders. It compares them to fetuses without these conditions to understand more about how these disorders affect development.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
Hear when a new Medical Termination of Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.